Top Story

Dose-escalation in IBD after CDI does not increase adverse outcomes risk

Dose-escalation in IBD after CDI does not increase adverse outcomes risk
October 17, 2017

ORLANDO — Initiating immunosuppressive medication following treatment for Clostridium difficile infection was not correlated with adverse clinical outcomes in patients with inflammatory bowel disease, according to a presenter here.

“Nearly 29,300 deaths are estimated from CDI annually in the United States,” Dana J. Lukin, MD, PhD, of Montefiore Medical Center, said during his presentation. “Rates of CDI and morbidity are significantly higher among patients with IBD when compared with those in the general population, with increased susceptibility to hypervirulent strains.”

Meeting News

Best colon cancer screening is ‘the one that gets done’

October 16, 2017
ORLANDO — Despite the wide variety in guidelines for colorectal cancer, an expert at the Postgraduate Course prior to the World Congress of Gastroenterology at ACG…
In the Journals

Genetic test shows promise for identifying pancreatic cysts at high risk for cancer

October 13, 2017
A novel genetic testing strategy developed at University of Pittsburgh Medical Center, which sequences mutations in pancreatic cyst fluid before surgery, showed high…
In the Journals

Intervention reduces unnecessary PPI use in patients with upper GI bleeding

October 9, 2017
A trainee-led intervention reduced unnecessary proton pump inhibitor infusions in patients hospitalized with upper GI bleeding, according to a research letter published…
More Headlines »

Ace the Case: A 52-Year-Old Black Female Who Presented to Her Primary Care Physician (PCP) With Increasing Fatigue and Muscle Aches

No commercial support for this activity.

This educational activity will utilize a case study to discuss a 52-year-old black female who presented to her primary…
More »
GI Bookshelf

Chapter 5: Bowel Obstruction And Pseudo-Obstruction

From GI Emergencies: A Quick Reference Guide
More »
Resource Centers
American College of Gastroenterology Annual Meeting

American College of Gastroenterology Annual Meeting

Meeting News Coverage

VIDEO: Expert outlines the advantages, disadvantages of biosimilars

October 21, 2015
More »